Skip to content

BIO KEY INTERNATIONAL INC: 10-Q filed 2023-11-20

What BIO KEY INTERNATIONAL INC reported in its quarterly report filed 2023-11-20 (fiscal Q3 2023): 46 published measures, 127 facts as tagged in accession 0001437749-23-032644.

This filing

Form
10-Q (quarterly report)
Filed
2023-11-20
Fiscal period
fiscal Q3 2023
Accession
0001437749-23-032644 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIO KEY INTERNATIONAL INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-09-309,749,380USD
At 2022-12-3111,344,255USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-09-306,434,929USD
At 2022-12-316,042,699USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-09-303,314,451USD
At 2023-06-303,845,091USD
At 2023-03-315,156,755USD
At 2022-12-315,301,556USD
At 2022-09-3011,198,508USD
At 2022-06-3013,619,539USD
At 2022-03-3115,381,555USD
At 2021-12-3115,615,455USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2023-09-30307,086USD
At 2022-12-312,635,522USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-637,824USD92
2023-01-01 to 2023-09-30-2,349,023USD273
2023-04-01 to 2023-06-30-1,422,878USD91
2023-01-01 to 2023-03-31-288,322USD90
2022-07-01 to 2022-09-30-2,402,509USD92
2022-01-01 to 2022-09-30-5,120,869USD273
2022-04-01 to 2022-06-30-1,718,957USD91
2022-01-01 to 2022-03-31-999,403USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-2,261,922USD273
2022-01-01 to 2022-09-30-4,328,403USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2023-01-01 to 2023-09-300USD273
2022-01-01 to 2022-09-3031,066USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-125,385USD273
2022-01-01 to 2022-09-3039,125USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2023-01-01 to 2023-09-300USD273
2022-01-01 to 2022-09-30-565,644USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-09-30-118,834,397USD
At 2022-12-31-116,485,373USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2023-07-01 to 2023-09-309,081,873shares92
2023-01-01 to 2023-09-309,042,319shares273
2022-07-01 to 2022-09-308,148,848shares92
2022-01-01 to 2022-09-308,054,207shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-0.07USD/shares92
2023-01-01 to 2023-09-30-0.26USD/shares273
2022-07-01 to 2022-09-30-0.29USD/shares92
2022-01-01 to 2022-09-30-0.64USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-189USD92
2023-01-01 to 2023-09-30142,811USD273
2022-07-01 to 2022-09-300USD92
2022-01-01 to 2022-09-300USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2023-09-3069,202USD
At 2022-12-31107,413USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-765,558USD92
2023-01-01 to 2023-09-30-2,302,483USD273
2022-07-01 to 2022-09-30-2,360,446USD92
2022-01-01 to 2022-09-30-4,927,474USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-09-307,820,339USD
At 2022-12-318,984,881USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2023-07-01 to 2023-09-3045,655USD92
2023-01-01 to 2023-09-30159,379USD273
2022-07-01 to 2022-09-302,071USD92
2022-01-01 to 2022-09-303,611USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-09-306,027,952USD
At 2022-12-315,455,688USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2023-09-301,656,107USD
At 2022-12-311,108,279USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2023-09-302,799,218USD
At 2022-12-311,522,784USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-07-01 to 2023-09-302,106,062USD92
2023-01-01 to 2023-09-307,229,298USD273
2022-07-01 to 2022-09-303,340,212USD92
2022-01-01 to 2022-09-308,734,132USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2023-09-304,289,213USD
At 2022-12-314,434,369USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2023-07-01 to 2023-09-301,340,504USD92
2023-01-01 to 2023-09-304,926,815USD273
2022-07-01 to 2022-09-30979,766USD92
2022-01-01 to 2022-09-303,806,658USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2023-07-01 to 2023-09-301,547,376USD92
2023-01-01 to 2023-09-305,422,272USD273
2022-07-01 to 2022-09-302,510,706USD92
2022-01-01 to 2022-09-306,315,277USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2023-07-01 to 2023-09-30558,686USD92
2023-01-01 to 2023-09-301,807,026USD273
2022-07-01 to 2022-09-30829,506USD92
2022-01-01 to 2022-09-302,418,855USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-09-309,501,669shares
At 2022-12-319,190,504shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2023-09-30122,263,106USD
At 2022-12-31122,028,612USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2023-09-30-115,208USD
At 2022-12-31-242,602USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2023-09-3050,465USD
At 2022-12-31197,355USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2023-09-3051,746USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2023-09-301,519,592USD
At 2022-12-311,762,825USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2023-09-301,080,032USD
At 2022-12-311,009,123USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2023-09-30362,250USD
At 2022-12-31342,706USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2023-09-30610,451USD
At 2022-12-31462,418USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

PeriodValueUnitDays
At 2023-09-30152,998USD
At 2022-12-31170,281USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-638,013USD92
2023-01-01 to 2023-09-30-2,206,212USD273
2022-07-01 to 2022-09-30-2,402,509USD92
2022-01-01 to 2022-09-30-5,120,869USD273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-602,460USD92
2023-01-01 to 2023-09-30-2,221,629USD273
2022-07-01 to 2022-09-30-2,521,778USD92
2022-01-01 to 2022-09-30-5,350,219USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2023-01-01 to 2023-09-3038,213USD273
2022-01-01 to 2022-09-3033,813USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2023-01-01 to 2023-09-30217,978USD273
2022-01-01 to 2022-09-30216,806USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2023-07-01 to 2023-09-30127,545USD92
2023-01-01 to 2023-09-3096,271USD273
2022-07-01 to 2022-09-30-42,063USD92
2022-01-01 to 2022-09-30-193,395USD273

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-20,000USD273
2022-01-01 to 2022-09-300USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2023-01-01 to 2023-09-30159,379USD273
2022-01-01 to 2022-09-303,661USD273

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2023-01-01 to 2023-09-30197,946USD273
2022-01-01 to 2022-09-30144,985USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-09-301,334,989USD273
2022-01-01 to 2022-09-30264,635USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-145,156USD273
2022-01-01 to 2022-09-30-47,993USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-09-30488,416USD273
2022-01-01 to 2022-09-30239,227USD273

Inspect the source

Entity
BIO KEY INTERNATIONAL INC / CIK 0001019034
Captured
2026-09-20T05:13:19.232Z
SEC response SHA-256
3b2eccf1278707a06dd03fc1ca5bba4cb0fbd996f85776a3748003ec5b74f966

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001019034.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))